156 related articles for article (PubMed ID: 2821896)
21. Synthesis and biological activities of 4-O-(difluoromethyl)-5-substituted-uracil nucleoside analogues.
Reefschläger J; Pein CD; Cech D
J Med Chem; 1988 Feb; 31(2):393-7. PubMed ID: 2828623
[TBL] [Abstract][Full Text] [Related]
22. Anti-herpes simplex virus and anti-human cell growth activity of E-5-propenyl-2'-deoxyuridine and the concept of selective protection in antivirus chemotherapy.
Cheng YC; Grill S; Ruth J; Bergstrom DE
Antimicrob Agents Chemother; 1980 Dec; 18(6):957-61. PubMed ID: 6263181
[TBL] [Abstract][Full Text] [Related]
23. The cytostatic activity of 5-(1-azidovinyl)-2'-deoxyuridine (AzVDU) against herpes simplex virus thymidine kinase gene-transfected FM3A cells is due to inhibition of thymidylate synthase and enhanced by UV light (lambda = 254 nm) exposure.
Balzarini J; Andrei G; Kumar R; Knaus EE; Wiebe LI; De Clercq E
FEBS Lett; 1995 Oct; 373(1):41-4. PubMed ID: 7589430
[TBL] [Abstract][Full Text] [Related]
24. 5-(5-Bromothien-2-yl)-2'-deoxyuridine and 5-(5-chlorothien-2-yl)-2'-deoxyuridine are equipotent to (E)-5-(2-bromovinyl)-2'-deoxyuridine in the inhibition of herpes simplex virus type I replication.
Wigerinck P; Pannecouque C; Snoeck R; Claes P; De Clercq E; Herdewijn P
J Med Chem; 1991 Aug; 34(8):2383-9. PubMed ID: 1652017
[TBL] [Abstract][Full Text] [Related]
25. Novel animal model for evaluating topical efficacy of antiviral agents: flux versus efficacy correlations in the acyclovir treatment of cutaneous herpes simplex virus type 1 (HSV-1) infections in hairless mice.
Lee PH; Su MH; Kern ER; Higuchi WI
Pharm Res; 1992 Aug; 9(8):979-89. PubMed ID: 1329068
[TBL] [Abstract][Full Text] [Related]
26. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with adenine arabinoside, 5-ethyldeoxyuridine, 5-iododeoxyuridine, and phosphonoacetic acid against herpes simplex virus types 1 and 2.
Ayisi NK; Gupta VS; Meldrum JB; Taneja AK; Babiuk LA
Antimicrob Agents Chemother; 1980 Apr; 17(4):558-66. PubMed ID: 6249191
[TBL] [Abstract][Full Text] [Related]
27. Comparative anti-herpesvirus activities of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, acyclovir, and two 2'-fluoropyrimidine nucleosides.
Smee DF; Campbell NL; Matthews TR
Antiviral Res; 1985 Oct; 5(5):259-67. PubMed ID: 2998275
[TBL] [Abstract][Full Text] [Related]
28. A new promising candidate to overcome drug resistant herpes simplex virus infections.
Zinser E; Krawczyk A; Mühl-Zürbes P; Aufderhorst U; Draßner C; Stich L; Zaja M; Strobl S; Steinkasserer A; Heilingloh CS
Antiviral Res; 2018 Jan; 149():202-210. PubMed ID: 29155164
[TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infections.
Hostetler KY; Rybak RJ; Beadle JR; Gardner MF; Aldern KA; Wright KN; Kern ER
Antivir Chem Chemother; 2001 Jan; 12(1):61-70. PubMed ID: 11437323
[TBL] [Abstract][Full Text] [Related]
30. 1-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-ethyluracil. A highly selective antiherpes simplex agent.
Mansuri MM; Ghazzouli I; Chen MS; Howell HG; Brodfuehrer PR; Benigni DA; Martin JC
J Med Chem; 1987 May; 30(5):867-71. PubMed ID: 3033244
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and antiviral activity of the carbocyclic analogues of (E)-5-(2-halovinyl)-2'-deoxyuridines and (E)-5-(2-halovinyl)-2'-deoxycytidines.
Herdewijn P; De Clercq E; Balzarini J; Vanderhaeghe H
J Med Chem; 1985 May; 28(5):550-5. PubMed ID: 2985782
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, antiviral and cytotoxic activity of 2'-deoxyuridines, 2'-fluoro-2'-deoxyuridines and 2'-arabinouridines containing 5-(1-hydroxy-2-halo-2-ethoxycarbonylethyl)-, 5-(1-hydroxy-2-iodo-2- carboxyethyl)- and 5-[1-hydroxy (or methoxy)-2-iodoethyl] substituents.
Kumar R; Wiebe LI; Knaus EE; Allen TM; Tempest ML
Drug Des Discov; 1992 Feb; 8(3):179-89. PubMed ID: 1326340
[TBL] [Abstract][Full Text] [Related]
33. New anti-HSV therapeutics target the helicase-primase complex.
Crumpacker CS; Schaffer PA
Nat Med; 2002 Apr; 8(4):327-8. PubMed ID: 11927930
[No Abstract] [Full Text] [Related]
34. Beta interferon plus gamma interferon efficiently reduces acyclovir-resistant herpes simplex virus infection in mice in a T-cell-independent manner.
Huang WY; Su YH; Yao HW; Ling P; Tung YY; Chen SH; Wang X; Chen SH
J Gen Virol; 2010 Mar; 91(Pt 3):591-8. PubMed ID: 19906941
[TBL] [Abstract][Full Text] [Related]
35. Effect of Azone upon the in vivo antiviral efficacy of cidofovir or acyclovir topical formulations in treatment/prevention of cutaneous HSV-1 infections and its correlation with skin target site free drug concentration in hairless mice.
Afouna MI; Fincher TK; Zaghloul AA; Reddy IK
Int J Pharm; 2003 Mar; 253(1-2):159-68. PubMed ID: 12593946
[TBL] [Abstract][Full Text] [Related]
36. Mode of action, toxicity, pharmacokinetics, and efficacy of some new antiherpesvirus guanosine analogs related to buciclovir.
Larsson A; Stenberg K; Ericson AC; Haglund U; Yisak WA; Johansson NG; Oberg B; Datema R
Antimicrob Agents Chemother; 1986 Oct; 30(4):598-605. PubMed ID: 3024562
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and antiviral activity of 5-thien-2-yl-2'-deoxyuridine analogues.
Wigerinck P; Kerremans L; Claes P; Snoeck R; Maudgal P; De Clercq E; Herdewijn P
J Med Chem; 1993 Mar; 36(5):538-43. PubMed ID: 8388474
[TBL] [Abstract][Full Text] [Related]
38. Preclinical assessment of topical treatments of herpes simplex virus infection: 5% (E)-5-(2-bromovinyl)-2'-deoxyuridine cream.
Freeman DJ; Sacks SL; De Clercq E; Spruance SL
Antiviral Res; 1985 Jun; 5(3):169-77. PubMed ID: 2992371
[TBL] [Abstract][Full Text] [Related]
39. Characterization of antiviral activity of a sesquiterpene, triptofordin C-2.
Hayashi K; Hayashi T; Ujita K; Takaishi Y
J Antimicrob Chemother; 1996 Apr; 37(4):759-68. PubMed ID: 8722541
[TBL] [Abstract][Full Text] [Related]
40. Treatment of experimental herpes simplex virus type 1 encephalitis in mice with (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil: comparison with bromovinyl-deoxyuridine and acyclovir.
Reefschläger J; Wutzler P; Thiel KD; Herrmann G
Antiviral Res; 1986 Mar; 6(2):83-93. PubMed ID: 3010858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]